Ab Astrazeneca, 10% Owner at Regulus Therapeutics Inc. (RGLS), sold 2,000,000 shares at $17.00 ($34.0M) on 2014-11-12, disclosed to the SEC on 2014-11-14.
Open-market sale of $34.0M RGLS by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.